title: Response to 'Dai W et al. Am J Cancer Res 2015;5(10):3270-3275' from the makers of nintedanib.
authors: Boehringer Ingelheim GmbH Ingelheim, Germany.
authors: Claudia-Nanette
authors: CN
authors: Gann
authors: Boehringer Ingelheim Corporation Reims, France.
authors: Nassim
authors: N
authors: Morsli
authors: Boehringer Ingelheim Shanghai Pharmaceuticals Co., Ltd.Shanghai, China; Current Address: Boehringer Ingelheim GmbHIngelheim, Germany.
authors: Xiaoxiang
authors: X
authors: Chen
authors: Boehringer Ingelheim Pharmaceuticals Ridgefield, CT, USA.
authors: José
authors: J
authors: Barrueco